Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Sedation During Monitored Anesthesia Care
NCT00398827Phase 3Completed
- Sponsor
- Pfizer
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine in Anesthesia (3 arms), sponsored by Pfizer. Primary endpoint: Percent of patients not requiring midazolam for rescue sedation. Started Dec 2006; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Anesthesia
Beyond the preview
Go deeper on NCT00398827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00398827.